IPO ChampIPO Insights
IPO Champ LogoIPO Champ Logo

IPOs

IPO Calendar
GMP Tracker
Subscription Status
Allotment Status
Stock Broker
  • Follow us on Instagram
  • Follow us on Facebook
  • Follow us on Threads
  • Follow us on YouTube
  • Follow us on Telegram
  • Follow us on WhatsApp
HomeIPOAspen Neuroscience, Inc.

About

Aspen Neuroscience, Inc.

Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative diseases. The company's develops ANPD001, an investigational single-dose, autologous dopaminergic neuronal precursor cell (DANPC) therapy for Parkinson's disease.

It operates in the United States. The company also advances additional cell replacement candidates targeting both sporadic and genetic forms of Parkinson's disease, as well as other candidates for conditions of the central nervous system (CNS).

Aspen Neuroscience, Inc. Overview

Ticker, listing venue and issuer profile

TickerASPE
ExchangeNASDAQ
Statusfiled
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CIK Code2124080
CUSIP044933109
ISINUS0449331091

Offer & Key Dates

Pricing terms and IPO milestones

Price Range$15.00 - $17.00
Offer Price$15.00
Listing Price$14.70
Current Price$14.89
Shares Offered9.38M
Shares Outstanding29.08M
Offer Size$140.63M
Market Cap$432.98M
Filing DateOct 09, 2026
Priced Date--
Listed DateOct 30, 2026

Live Market Snapshot

Real-time price and trading activity

$14.89+1.29% All time

USD · NASDAQ:NASDAQ:ASPE

Open$14.70
High$14.90
Low$11.60
Volume1,322,735
52W High--
52W Low--
Market Cap$432.98M
Enterprise Value--

Valuation & Multiples

Key valuation ratios and metrics

P / E--
P / Book--
P / Sales--
EV / EBITDA--
EPS--
Revenue / Share (TTM)--
Revenue$0.00
Net Income-$62.06M

Financial Health

Balance sheet strength and liquidity

Total Debt$348.58M
Total Assets$110.28M
Cash$82.10M
Free Cash Flow--
Current Ratio4.56
Quick Ratio4.56
Debt / Equity--
CapEx--

Financial Highlights

Historical financial performance

SEC Filings

Official documents from SEC EDGAR

FormFiling DateDocument
424B4Oct 30, 2026Prospectus
EFFECTOct 29, 2026Notice of Effectiveness
CERTOct 29, 2026Certification by an exchange approving securities for listing
8-A12BOct 29, 2026Registration of securities
S-1/AOct 26, 2026[Amend] General form for registration of securities under the Securities Act of 1933
S-1/AOct 22, 2026[Amend] General form for registration of securities under the Securities Act of 1933
S-1Oct 9, 2026General form for registration of securities under the Securities Act of 1933
DRS/AJun 10, 2026[Amend] [Cover] Draft Registration Statement
DRS/AMay 12, 2026[Amend] [Cover] Draft Registration Statement
DRSMar 30, 2026[Cover] Draft Registration Statement

Company Info

Contact and headquarters details

Websitehttps://www.aspenneuroscience.com
HeadquartersUnited States
Founded2018
Employees120
Phone(858) 263-1222
Address10835 Road to the Cure, Suite 100San Diego, California 92121United States

Leadership

Key executives and officers

DM

Damien McDevitt, Ph.D.

President, Chief Executive Officer and Director

FH

Faheem Hasnain

Executive Chairman

DM

Dalen Meeter

Chief Financial Officer

LJ

Lisa Johnson-Pratt, M.D.

Sasineprocel Development Lead and Chief Commercial Officer

KR

Kim Raineri

Chief Technology Officer

JB

Jeffrey Boerneke

General Counsel and Secretary

TD

Thomas Daniel, M.D.

Director

DF

Douglas Fisher, M.D.

Director

CP

Cindy Perettie

Director

CP

Caryn Peterson

Director

Aspen Neuroscience, Inc. IPO - FAQs

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ASPEN NEUROSCIENCE INC stocks are traded under the ticker ASPE.

Quick Facts

Exchange
NASDAQ
Ticker
ASPE
Deal Type
IPO
Offer Size
$140.63M
Market Cap
$432.98M
Shares Offered
9.38M

Company Info

Website
https://www.aspenneuroscience.com
Headquarters
United States
Founded
2018
Employees
120
Phone
(858) 263-1222
Address
10835 Road to the Cure, Suite 100San Diego, California 92121United States
IPO Champ LogoIPO Champ Logo

IPO Champ helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO CalendarGMP TrackerSubscription StatusAllotment Status

IPOs

All IPOsLive IPOsUpcoming IPOsClosed IPOsListed IPOs

Resources

NewseBooks

Company

HomeAbout UsPrivacy PolicyTerms of Service

About IPO Champ

IPO Champ is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@ipochamp.com.

Please read all offer documents and risk disclosures carefully before investing. IPO Champ does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Champ. All rights reserved.

Want to stay updated?Subscribe to our newsletter

Aspen Neuroscience, Inc.

Aspen Neuroscience, Inc.

ASPENASDAQ
filed

Issue Size

$140.63M

Price Range

$15.00 - $17.00

Shares

29.08M o/s · 9.38M offered

Listing Price

$14.70

Probable listing

Oct 30, 2026

Sector

Healthcare

Filed

Oct 09, 2026